Mold and Autism with Christian Bogner MD

We interviewed Christian Bogner MD CFMNP FACOG about mold and autism. You can listen to the replay below.

Mold and Autism

There are a few documented cases of the complete reversal of autism symptoms with the treatment of the mycotoxins produced by mold. In one case, such as this peer-reviewed article by Drs. Sidney Baker and William Shaw, it was achieved with antifungal drugs. In another case, it was achieved with the removal of a child from a home with unseen mold in addition to biomedical interventions for the child.

In such cases, the child is typically tested with a special urine test such as Great Plains Laboratory’s MycoTox Profile that looks for biochemical markers consistent with fungal (Aspergillus) colonization of the gastrointestinal tract. Additional tests could include testing for certain SNPs (single nucleotide polymorphisms) in the child’s DNA as well as testing for neurotransmitter imbalances.

Another way to test the hypothesis that mold in the home and child are causing symptoms of autism is to remove the child from the home for a period of time, such as when going on vacation for a few days or a week. If symptoms improve, this is a strong indicator that something in the child’s home environment could be contributing to the total load of symptoms.

Yet another way to test the mold hypothesis is to give the child the antifungal probiotic Saccharomyces boulardii (under a practitioner’s guidance, of course). A dramatic Herxheimer reaction provides a strong indications that mold colonization might be a factor.

In our experience, if you’ve tried everything in getting to the root of your child’s autism symptoms, you’ll want to investigate mold as a factor. It could be *the* one major thing that needs to be addressed.

In This Webinar

Dr. Christian Bogner uses a functional-medicine approach to treat children with autism. He uses a variety of testing methodologies to confirm his hypothesis that mold may be playing a factor in autism symptoms. In this webinar, he’ll help us to understand:

When should mold be suspected as a cause of autism symptoms?
How common is mold illness/exposure in a child with autism? (Answer: Very. Of the hundreds of Dr. Bogner’s autism cases, only one child did not have mold as a factor.)
What kind of symptoms does a person with mold and mycotoxin illness exhibit?
Which tests can be used for the child to determine if mold is a factor?
Which diet(s) can help with mold and mycotoxin illness?
Are there common foods that are a concern for mold and mycotoxin illness?
How can a home be tested for mold?
Do most homes have mold?
Is it worth spending tens of thousands of dollars or more to remediate a mold-infested home?
What kinds of treatments help with mold and mycotoxin illness?
What are examples of success stories of children with autism who have been treated for mold?
What is the role of EMFs (electromagnetic frequencies) on mold and autism?
How glyphosate, heavy metals and other toxins contribute to the total load on a body and impede the immune system from doing its job of getting rid of mycotoxins and biotoxins.
Why PANS/PANDAS, Lyme disease, HHV-6 and other infections tend to also be present in a child with mold illness and/or autism.
Why Mast Cell Activation Syndrome is common in a child with mold illness and/or autism.

Please note that you will be asked to provide your email address at the 30-minute mark to continue viewing the replay.

About Christian Bogner MD CFMNP FACOG

Dr. Christian Bogner is a lecturer, educator and experienced practicing clinician. His services specialize in online education for his patients.

He is a functional medicine certified physician with additional board certification in OBGYN. He has obtained his certification in Plant-Based-Nutrition from Cornell University.

He provides functional medicine education and counseling as the CEO of Bogner Health, LLC in Michigan, which offers laboratory test interpretation education for individuals with complex medical conditions such as autoimmune diseases and mental health disorders.

Dr. Bogner is a clinical consultant for MaxGen Labs, LLC, a nutrigenomics lab analyzing genetic data, utilized by over 800 practitioners around the world. He has lectured throughout the United States and abroad regarding integrative approaches to disease with a focus on genetics, neurotransmitters and toxicities. You can find out more about him and his practice at his website https://www.drbognerhealth.com/

Disclaimer

This webinar is not a substitute for medical advice, treatment, diagnosis, or consultation with a medical professional. It is intended for general informational purposes only and should not be relied on to make determinations related to treatment of a medical condition. Epidemic Answers has not verified and does not guaranty the accuracy of the information provided in this webinar.

Still Looking for Answers?

Visit the Epidemic Answers Provider Directory to find a practitioner near you.

Sources & References

Baker, S., et al. Case Study: Rapid Complete Recovery From An Autism Spectrum Disorder After Treatment of Aspergillus With The Antifungal Drugs Itraconazole And Sporanox. Integr Med (Encenitas). 2020 Aug;19(4):20-27.

Bennett, J.W., et al. Mycotoxins. Clinical Microbiology Reviews. Jul 2003: 497-516.

Berndtson, K., et al. Medically sound investigation and remediation of water-damaged buildings in cases of CIRS-WDB. Center for Research on Biotoxin Associated Illness. 2016 Jan 19.

Berry, Y. A Physician’s Guide to Understanding and Treating Biotoxin Illness. 2014.

de Allori, M.C.G., et al. Antimicrobial resistance and production of biofilms in clinical isolates of coagulase-negative Staphylococcus strains. Biol Pharm Bull. 2006 Aug;29(8):1592-6.

De Santis, B., et al. Role of mycotoxins in the pathobiology of autism: A first evidence. Nutr Neurosci. 2019 Feb;22(2):132-144.

De Santis, B., et al. Study on the Association among Mycotoxins and other Variables in Children with Autism. Toxins (Basel). 2017 Jun 29;9(7):203.

Hope, J. A review of the mechanism of injury and treatment approaches for illness resulting from exposure to water-damaged buildings, mold, and mycotoxins. ScientificWorldJournal. 2013 Apr 18;2013:767482.

Hudnell, H.K. Chronic biotoxin-associated illness: multiple-system symptoms, a vision deficit, and effective treatment. Neurotoxicol Teratol. Sep-Oct 2005;27(5):733-43.

Institute of Medicine (US) Committee on Damp Indoor Spaces and Health. Damp Indoor Spaces and Health. Washington (DC): National Academies Press (US); 2004.

Kali, A. Antibiotics and bioactive natural products in treatment of methicillin resistant Staphylococcus aureus: A brief review. Pharmacogn Rev. Jan-Jun 2015;9(17):29-34.

Kontoyiannis, D.P., et al. Treatment principles for the management of mold infections. Cold Spring Harb Perspect Med. 2014 Nov 6;5(4):a019737.

Oliva, A., et al. High Potency of Melaleuca alternifolia Essential Oil against Multi-Drug Resistant Gram-Negative Bacteria and Methicillin-Resistant Staphylococcus aureus. Molecules. 2018 Oct 9;23(10):2584.

Ratnaseelen, A.M., et al. Effects of Mycotoxins on Neuropsychiatric Symptoms and Immune Processes. Clin Ther. 2018 Jun;40(6):903-917.

Salari, M.H., et al. Antibacterial effects of Eucalyptus globulus leaf extract on pathogenic bacteria isolated from specimens of patients with respiratory tract disorders. Clin Microbiol Infect. 2006 Feb;12(2):194-6.

Shoemaker, R.C., et al. Sick building syndrome (SBS) and exposure to water-damaged buildings: time series study, clinical trial and mechanisms. Neurotoxicol Teratol. Sep-Oct 2006;28(5):573-88.

Shoemaker, R.C., et al. Structural brain abnormalities in patients with inflammatory illness acquired following exposure to water-damaged buildings: a volumetric MRI study using NeuroQuant®. Neurotoxicol Teratol. Sep-Oct 2014;45:18-26.

Shoemaker, R.C., et al. A time-series study of sick building syndrome: chronic, biotoxin-associated illness from exposure to water-damaged buildings. Neurotoxicol Teratol. Jan-Feb 2005;27(1):29-46.